Osteoporosis in men

Osteoporosis International

Volumn 9, Issue SUPPL. 2, 1999, Pages

  Seeman, E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SEX HORMONE; SOMATOMEDIN C;

AGING; ARTICLE; BIOCHEMISTRY; BONE DENSITY; BONE MASS; CALCIUM ABSORPTION; CORTICAL BONE; FEMUR FRACTURE; HUMAN; MALE; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; PATHOGENESIS; PRIORITY JOURNAL; TRABECULAR BONE; VERTEBRA FRACTURE;

AGING; ANDROGENS; BONE AND BONES; BONE DENSITY; CALCIUM; DIPHOSPHONATES; FEMORAL FRACTURES; HUMANS; MALE; OSTEOPOROSIS; PARATHYROID HORMONE; SPINAL FRACTURES;

EID: 0032942602     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00004168     Document Type: Article

References (99)

1. Cooper C, Campion G, Melton LJ. Hip fractures in the elderly: a world-wide projection. Osteoporos Int 1992;2:285-9.
2. Kanis JA, Pitt FA. Epidemiology of osteoporosis. Bone 1992;13:S7-15.
3. Kannus P, Parkkari J, Sievanen H, Heinonen A, Vuori I, Jarvinen M. Epidemiology of hip fractures. Bone 1996;18:557-61.
4. Melton LJ III, Atkinson EJ, Madhok R. Downturn in hip fracture incidence. Public Health Rep 1996;111:146-50.
5. Elffors I, Allander E, Kanis JA, et al. The variable incidence of hip fracture in Southern Europe: the MEDOS Study. Osteoporos Int 1994;4:253-63.
6. Melton LJ III, Therneau TM, Larson DR. Long-term trends in hip fracture prevalence: the influence of hip fracture incidence and survival. Osteoporos Int 1998;8:68-74.
7. Bacon WE, Maggi S, Looker A, Harris T, Nair CR, Giaconi J, et al. International comparison of hip fracture rates in 1988-89. Osteoporos Int 1996;6:69-75.
8. Maggi S, Kelsey JL, Litvak J, Heyse SP. Incidence of hip fractures in the elderly: a cross-national analysis. Osteoporos Int 1991;1:232-11.
9. Poór G, Atkinson EJ, O'Fallon WM, Melton LJ III. Determinants of reduced survival following hip fractures in men. Clin Orthop Rel Res 1995;319:260-5.
10. Diamond TH, Thornley SW, Sekel R, Smerdely P. Hip fracture in elderly men: prognostic factors and outcomes. Med J Aust 1997;167:412-5.
11. Lu-Yao GL, Baron JA, Barrett JA, Fisher ES. Treatment and survival among elderly Americans with hip fractures: a population-based study. Am J Public Health 1994;84:1287-91.
12. Jones G, Nguyen T, Sambrook PN, Kelly PJ, Gilbert C, Eisman JA. Symptomatic fracture incidence in elderly men and women: the Dubbo Osteoporosis Epidemiology Study (DOES). Osteoporos Int 1994;4:277-82.
13. O'Neill TW, Felsenberg D, Varlow J, Cooper C, Kanis JA, Silman AJ. The prevalence of vertebral deformity in European men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res 1996;11:1010-8.
14. Tsai K-S, Twu S-J, Chieng P-U, Yang R-S, Lee T-K. Prevalence of vertebral fractures in Chinese men and women in urban Taiwanese communities. Calcif Tissue Int 1996;59:249-53.
15. Burger H, van Daele PLA, Grashuis K, et al. Vertebral deformities and functional impairment in men and women. J Bone Miner Res 1997;12:152-7.
16. Davies KM, Stegman MR, Heaney RP, Recker RR. Prevalence and severity of vertebral fracture: the Saunders County Bone Quality Study. Osteoporos Int 1996;2:160-5.
17. Seeman E. The dilemma of osteoporosis in men. Am J Med 1995;98(Suppl 1A):S75-87.
18. Rupich RC, Specker BL, Lieuw-A-Fa M, Ho M. Gender and race differences in bone mass during infancy. Calcif Tissue Int 1996;58:395-7.
19. Gilsanz V, Boechat MI, Roe TF, Loro ML, Sayre JW, Goodman WG. Gender differences in vertebral body sizes in children and adolescents. Radiology 1994;190:673-7.
20. Gilsanz V, Skaggs DI, Kevanikaya A, et al. Differential effects of race on the axial and appendicular skeleton of children. J Clin Endocrinol Metab 1998;68:1420-7.
21. Gilsanz V, Boechat MI, Gilsanz R, Loro ML, Roe TF, Goodman WG. Gender differences in vertebral size in adults: biomechanical implications. Radiology 1994;190:678-94.
22. Han Z-H, Palnitkar S, Rao DS, Nelso D, Parfitt AM. Effect of ethnicity and age or menopause on the structure and geometry of iliac bone. J Bone Miner Res 1996;11:1967-75.
23. Parfitt AM. Perspective: a structural approach to renal bone disease. J Bone Miner Res 1998;13:1213-20.
24. Preece MA. The development of skeletal sex differences at adolescence. In: Russo P, Gass G, editors. Human adaptation. Sydney: Department of Biological Sciences, Cumberland College of Health Sciences, 1982:1-13.
25. Preece MA, Pan H, Ratcliffe SG. Auxological aspects of male and female puberty. Acta Paediatr 1992;383:11-3.
26. Garn SM. In: The earlier gain and later loss of cortical bone. Springfield: CC Thomas, 1970.
27. Garn SM, Nagy JM, Sandusky ST. Differential sexual dimorphism in bone diameters of subjects of European and Africa Ancestry. Am J Phys Anthrop 1972;37:127-30.
28. Lu PW, Cowell CT, Lloyd-Jones SA, Brody JN, Howman-Giles R. Volumetric bone mineral density in normal subjects aged 5-27 years. J Clin Endocrinol Metab 1996;81:1586-90.
29. Zamberlan N, Radetti G, Paganini C, Gatti D, Rossini M, Braga V. Evaluation of cortical thickness and bone density by roentgen microdensitometry in growing males and females. Eur J Pediatr 1996;155:377-82.
30. Kalender WA, Felsenberg D, Louis O, et al. Reference values for trabecular and cortical vertebral bone density in single and dual-energy quantitative computed tomography. Eur J Radiol 1989;9:75-80.
31. Kuiper JW, van Kuijk C, Grashuis JL, Ederveen AGH, Schotte HE. Accuracy and the influence of marrow fat on quantitative CT and dual-energy X-ray absorptiometry measurements of the femoral neck in vitro. Osteoporos Int 1996;6:25-30.
32. Ruff CB, Hayes WC. Sex differences in age-related remodeling of the femur and tibia. J Orthop Res 1988;6:886-96.
33. Jones G, Nguyen T, Sambrook P, Kelly PJ, Eisman JA. Progressive loss of bone in the femoral neck in elderly people: longitudinal findings from the Dubbo osteoporosis epidemiology study. BMJ 1994;309:691-5.
34. Hannan MT, Kiel DP, Mercier CE, Anderson JJ, Felson DT. Longitudinal bone mineral density change in elderly men and women: the Framingham osteoporosis study [abstract]. J Bone Miner Res 1994;9(Suppl 1):S130.
35. Laval-Jeantet A-M, Bergot C, Carroll R, Garcia-Schaefer F. Cortical bone senescence and mineral bone density of the humerus. Calcif Tissue Int 1983;35:268-72.
36. Vega E, Ghiringhelli G, Mautalen C, Valzacchi GR, Scaglia H, Zylberstein C. Bone mineral density and bone size in men with primary osteoporosis and vertebral fractures. Calcif Tissue Int 1998;62:465-9.
37. Duan Y, Seeman E. Unpublished data.
38. Bergman RJ, Gazit D, Kahn AJ, Gruber H, McDougall S, Hahn TJ. Age-related changes in osteogenic stem cells in mice. J Bone Miner Res 1996:11:568-77.
39. Jilka RL, Weinstein RS, Takahashi K, Parfitt AM, Manolagas SC. Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence. J Clin Invest 1996;97:1732-40.
40. Kajkenova O, Lecka-Czernik B, Gubrij I, et al. Increased adipogenesis and myelopoiesis in the bone marrow of SAMP6, a murine model of defective osteoblastogenesis and low turnover osteopenia. J Bone Miner Res 1997;12:1772-9.
41. Weinstein RS, Jilka R, Parfitt AM, Manolagas SC. The effects of androgen deficiency on murine bone remodeling and bone mineral density are mediated via cells of the osteoblastic lineage. Endocrinology 1997;138:4013-21.
42. Marie PJ, deVernejoul MC, Connes D, Hott M. Decreased DNA synthesis by cultured osteoblastic cells in eugonadal osteoporotic men with defective bone formation. J. Clin Invest 1991;88:1167-72.
43. Johansson AG, Eriksen EF, Lindh E, et al. Reduced serum levels of the growth hormone-dependent insulin-like growth factor binding protein and a negative bone balance at the level of individual remodeling units in idiopathic osteoporosis in men. J Clin Edocrinol Metab 1997;82:2795-8.
44. Sone T, Miyake M, Takeda N, Fukunaga M. Urinary excretion of type I collagen crosslinked N-telopeptides in healthy Japanese adults: age-and sex-related changes and reference limits. Bone 1995;17:335-9.
45. Wishart JM, Need AG, Horowitz M, Morris HA, Nordin BEC. Effect of age on bone density and bone turnover in men. Clin Endocrinol 1995;42:141-6.
46. Resch H, Pietschmann P, Woloszczuk W, Krexner E, Bernecker P, Willvonseder R. Bone mass and biochemical parameters of bone metabolism in men with spinal osteoporosis. Eur J Clin Invest 1992;22:542-5.
47. Sharp CA, Worsfold M, Rowlands PR, Davie MWJ. Accurate prediction of spinal osteoporosis in men using a biochemical measure of collagen balance [abstract]. Bone 1994;15:243.
48. Need AG, Morris HA, Horowitz M, Scopacasa F, Nordin BEC. Intestinal calcium absorption in men with spinal osteoporosis. Clin Endocrinol 1998;48:163-8.
49. Gomez C. Bone mineral density in hip fracture: the Spanish Multi-Centre Study [abstract]. Calcif Tissue Int 1994;55:440.
50. Somjen D, Mor Z, Kaye AM. Age dependence and modulation by gonadectomy of the sex-specific response of rat diaphyseal bone to gonadal steroids. Endocrinology 1994;134:809-14.
51. Schwanz Z, Nasatzky E, Ornoy A, Brooks BP, Soskolne WA, Boyan BD. Gender-specific, maturation-dependent effects of testosterone on chondrocytes in culture. Endocrinology 1994;134:1640-7.
52. Kasperk CH, Wakley GK, Hierl T, Ziegler R. Gonadal and adrenal androgens are potent regulators of human bnoe cell metabolism in vitro. J Bone Miner Res 1997;12:464-71.
53. Gunness M, Orwoll E. Early induction of alterations in cancellous and cortical bone histology after orchiectomy in mature rats. J Bone Miner Res 1995:10:1735-44.
54. Vanderschueren D, Van Herck E, Geusens P, et al. Androgen resistance and deficiency have different effects on the growing skeleton of the rat. Calcif Tissue Int 1994;55:198-203.
55. Wakley GK, Evans GL, Turner RT. Short-term effects of high dose estrogen on tibiae of growing male rats. Calcif Tissue Int 1997;60:37-42.
56. Smith EP, Boyd J, Frank GR, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 1994;331:1056-61.
57. Vanderschueren D, Van Herck E, Nijs J, Ederveen AGH, de Coster R, Bouillon R. Aromatase inhibition impairs skeletal modeling and decreases bone mineral density in growing male rats. Endocrinology 1997;138:2301-7.
58. Zhang XZ, Kalu DN, Erbas B, Hopper JL, Seeman E. The effects of gonadectomy on bone size, mass, and volumetric density in growing rats may be gender-, site-and growth hormone dependent. J Bone Miner Res (in press).
59. Urban RJ, Veldhuis JD, Blizzard RM, Dufau ML. Attenuated release of biologically active luteinizing hormone in healthy aging men. J Clin Invest 1988;81:1020-9.
60. Haji M, Tanaka S, Nish Y, et al. Sertoli cell function declines earlier than Leydig cell function in aging Japanese men. Maturitas 1994;18:143-53.
61. Rudman D, Drinka PJ, Wilson CR, et al. Relations of endogenous anabolic hormones and physical activity to bone mineral density and lean body mass in elderly men. Clin Endocrinol 1994;40:653-61.
62. Seeman E, Melton LJ, O'Fallon WM, Riggs BL. Risk factors for osteoporosis in males. Am J Med 1983;75:977-82.
63. Stanley HL, Schmitt BP, Poses RM, Diess WP. Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men? J Am Geriatr Soc 1991;39:766-71.
64. Boonen S, Vanderschueren D, Cheng XG, et al. Age-related (type II) femoral neck osteoporosis in men: biochemical evidence for both hypovitaminosis D-and androgen deficiency-induced bone resorption. J Bone Miner Res 1997;12:2119-26.
65. Turner RT, Hannon KS, Demers LM, Buchanan J, Bell NH. Differential effects of gonadal function on bone histomorphometry in male and female rats. J Bone Miner Res 1989;4:557-62.
66. Vanderschueren D, Van Herck E, de Coster R, Bouillon R. Aromatization of andrgens is important for skeletal maintenance of aged male rats. Calcif Tissue Int 1996;59:179-83.
67. Greendale GA, Edelstein S, Barrett-Connor E. Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study. J Bone Miner Res 1997;12:1833-43.
68. Slemenda CW, Longcope C, Zhou L, Hui SL, Peacock M, Johnston CC. Sex steroids and bone mass in older men: positive associations with serum estrogens and negative associations with androgens. J Clin Invest 1997;100:1755-9.
69. Rosen CJ, Donahue LR, Hunter SJ. Insulin-like growth factors and bone: the osteoporosis connection. Proc Soc Exp Biol Med 1994;206:83-102.
70. Poehlman ET, Copeland KC. Influence of physical activity on insulin-like growth factor-1 in healthy younger and older men. J Clin Endocrinol 1990;71:1468-73.
71. Felsing NE, Brasel JA, Cooper DM. Effect of low and high intensity exercise on circulating growth hormone in men. J Clin Endocrinol Metab 1992;75:157-62.
72. Johansson AG, Forslundm A, Hambraeus L, Blum WF, Ljunghall S. Growth hormone dependent insulin like growth factor binding protein is a major determinant of bone mienral density in healthy men. J Bone Miner Res 1994;9:915-21.
73. Wuster C, Blum WF, Schlemilch S, Ranke MB, Ziegler R. Decreased serum levels of insulin-like growth factors and IGF binding protein 3 in osteoporosis. J Intern Med 1993;234:249-55.
74. Kurland ES, Rosen CJ, Cosman F, et al. Insulin-like growth factor-I in men with idiopathic osteoporosis. J Clin Endocrinol Metab 1997;82:2799-805.
75. Morales AJ, Nolan JJ, Nelson CJ, Yen SSC. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 1994;78:1360-7.
76. Hobbs CJ, Plymate SR, Rosen CJ, Adler RA. Testosterone administration increases insulin-like growth factor-1 levels in normal men. J Clin Endocrinol Metab 1993;77:776-9.
77. Weissberger AJ, Ho KKY. Activation of the somatotropic axis by testosterone in adult males: evidence for the role of aromatization. J Clin Endocrinol Metab 1993;76:1407-12.
78. Ho KY, Evans WS, Blizzard RM, et al. Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 1987;64:51-8.
79. Wright NM, Renault J, Willi S, et al. Greater secretion of growth hormone in black than in white men: possible factor in greater bone mineral density, a clinical research center study. J Clin Endocrinol Metab 1995;80:2291-7.
80. Horton R, Pasupuletti V, Antonipillai I. Androgen induction of steroid 5 alpha reductase may be mediated via insulin-like growth factor-1. Endocrinology 1993;133:447-51.
81. Jansson JO, Eden S, Isaksson O. Site of action of testosterone and estradiol on longitudinal bone growth. Am J Physiol 1983;244:E135-40.
82. Budy AM, Urist MR, McLean FC. The effect of estrogens on the growth apparatus of the bones of immature rats. Am J Pathol 1952;28:1143-53.
83. Yeh JK, Chen M-M, Aloia JF. Ovariectomy-induced high turnover in cortical bone is dependent on pituitary hormone in rats. Bone 1996;18:443-50.
84. Yeh JK, Chen M-M, Aloia JF. Effects of estrogen and growth hormone of skeleton in the ovariectomized rat with hypophysectomy. Am J Physiol 1997;36:E734-42.
85. Olle GP, Isaksson A, Lindahl A, Nilsson A, Isgaard J. Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocr Rev 1987;8:426-38.
86. Ross P. Personal communication.
87. Ross P. Personal communication. 87. Cheng S, Suominen H, Sakari-Rantala R, Laukkanen P, Avikainen V, Heikkinen E. Calcaneal bone mineral density predicts fracture occurrence: a five-year follow-up study in elderly people. J Bone Miner Res 1997;12:1075-82.
88. Lunt M, Felsenberg D, Reeve J, et al. Bone density variation and its effects on risk of vertebral deformity in men and women studied in thirteen European centers: the EVOS study. J Bone Miner Res 1997;12:1883-94.
89. Nyquist F, Gärdsell P, Sernbo I, Jeppsson JO, Johnell O. Assessment of sex hormones and bone mineral density in relation to occurrence of fracture in men: a prospective population-based study. Bone 1998;22:147-51.
90. Anderson FH, Francis RM, Bishop JC, Rawlings DJ. Effect of intermittent cyclical disodium etidronate therapy on bone mineral density in men with vertebral fractures. Age Ageing 1997;26:359-65.
91. Leifke E, Körner H-C, Link TM, Behre HM, Peters PE. Effects of testosterone replacement therapy on cortical and trabecular bone mineral density, vertebral body area and paraspinal muscle area in hypogonadal men. Eur J Endocrinol 1998;138:51-8.
92. Behre HM, Kliesch S, Leifke E, Link TM, Nieschlag E. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab 1997;82:2386-90.
93. Katznelson L, Finkelstein JS, Schoenfeld DA, Rosenthal DI, Anderson EJ, Klibanski A. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab 1996;81:4358-65.
94. Anderson FH, Francis RM. Faulkner K. Androgen supplementation in eugonadal men with osteoporosis: effects of 6 months of treatment on bone mineral density and cardiovascular risk factors. Bone 1996;18:171-7.
95. Bhasin S, Storer TW, Herman N, et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med 1996;335:1-7.
96. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years or older. N Engl J Med 1997;337:666-70.
97. Orwell WES, Oviatt SK, McClung MR, Deftos LJ, Sexton G. The rate of bone mineral loss in normal men and the effects of calcium and cholecalciferol supplementation. Ann Intern Med 1990;112:29-34.
98. Ringe JD, Dorst A, Kipshoven C, Rovati LC, Setnikar I. Avoidance of vertebral fractures in men with idiopathic osteoporosis by a three year therapy with calcium and low-dose intermittent monofluorophosphate. Osteoporos Int 1998;8:47-52.
99. Johansson AG, Lindh E, Blum WF, Kollerup G, Sorensen OH, Ljunghall S. Effects of growth hormone and insulin-like growth factor I in men with idiopathic osteoporosis. J Clin Endocrinol Metab 1996;81:44-8.